| Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes R Cristescu, J Lee, M Nebozhyn, KM Kim, JC Ting, SS Wong, J Liu, ... Nature medicine 21 (5), 449-456, 2015 | 1822 | 2015 |
| Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma WK Sung, H Zheng, S Li, R Chen, X Liu, Y Li, NP Lee, WH Lee, ... Nature genetics 44 (7), 765-769, 2012 | 971 | 2012 |
| FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors J O'Neil, J Grim, P Strack, S Rao, D Tibbitts, C Winter, J Hardwick, ... The Journal of experimental medicine 204 (8), 1813-1824, 2007 | 790 | 2007 |
| Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins JS Hardwick, FG Kuruvilla, JK Tong, AF Shamji, SL Schreiber Proceedings of the National Academy of Sciences 96 (26), 14866-14870, 1999 | 684 | 1999 |
| Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12–rapamycinassociated protein RT Peterson, BN Desai, JS Hardwick, SL Schreiber Proceedings of the National Academy of Sciences 96 (8), 4438-4442, 1999 | 585 | 1999 |
| Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma Z Kan, H Zheng, X Liu, S Li, TD Barber, Z Gong, H Gao, K Hao, ... Genome research 23 (9), 1422-1433, 2013 | 558 | 2013 |
| Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes G Garcia-Manero, H Yang, C Bueso-Ramos, A Ferrajoli, J Cortes, ... Blood, The Journal of the American Society of Hematology 111 (3), 1060-1066, 2008 | 529 | 2008 |
| Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study E Galanis, KA Jaeckle, MJ Maurer, JM Reid, MM Ames, JS Hardwick, ... Journal of clinical oncology 27 (12), 2052, 2009 | 401 | 2009 |
| Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized … BL Rapoport, K Jordan, JA Boice, A Taylor, C Brown, JS Hardwick, ... Supportive Care in Cancer 18, 423-431, 2010 | 291 | 2010 |
| Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non–Small-Cell Lung Cancer JF Gainor, D Tseng, S Yoda, I Dagogo-Jack, L Friboulet, JJ Lin, ... JCO precision oncology 1, 1-13, 2017 | 264 | 2017 |
| Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol—EASE S Grunberg, D Chua, A Maru, J Dinis, S DeVandry, JA Boice, JS Hardwick, ... Journal of Clinical Oncology 29 (11), 1495-1501, 2011 | 260 | 2011 |
| Activation of the Lck tyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394. JS Hardwick, BM Sefton Proceedings of the National Academy of Sciences 92 (10), 4527-4531, 1995 | 218 | 1995 |
| Development of vorinostat: current applications and future perspectives for cancer therapy VM Richon, J Garcia-Vargas, JS Hardwick Cancer letters 280 (2), 201-210, 2009 | 191 | 2009 |
| Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers A Saadi, NB Shannon, P Lao-Sirieix, M O’Donovan, E Walker, ... Proceedings of the National Academy of Sciences 107 (5), 2177-2182, 2010 | 175 | 2010 |
| Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing SS Wong, KM Kim, JC Ting, K Yu, J Fu, S Liu, R Cristescu, M Nebozhyn, ... Nature communications 5 (1), 5477, 2014 | 171 | 2014 |
| Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells SS Rao, J O'Neil, CD Liberator, JS Hardwick, X Dai, T Zhang, E Tyminski, ... Cancer research 69 (7), 3060-3068, 2009 | 158 | 2009 |
| A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia CJ Peters, JRE Rees, RH Hardwick, JS Hardwick, SL Vowler, CAJ Ong, ... Gastroenterology 139 (6), 1995-2004. e15, 2010 | 157 | 2010 |
| Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma KG Paulson, A Tegeder, C Willmes, JG Iyer, OK Afanasiev, D Schrama, ... Cancer immunology research 2 (11), 1071-1079, 2014 | 134 | 2014 |
| A phase I pharmacokinetic and pharmacodynamic study of dalotuzumab (MK-0646), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in patients with advanced solid … F Atzori, J Tabernero, A Cervantes, L Prudkin, J Andreu, ... Clinical Cancer Research 17 (19), 6304-6312, 2011 | 130 | 2011 |
| The activated form of the Lck tyrosine protein kinase in cells exposed to hydrogen peroxide is phosphorylated at both Tyr-394 and Tyr-505 JS Hardwick, BM Sefton Journal of Biological Chemistry 272 (41), 25429-25432, 1997 | 95 | 1997 |
Andrey LobodaDirector, Computational and Systems Biology, MerckVerified email at merck.com
